Clinical Trials Update: Feb. 2, 2011

Emphysema/COPDAlzheimer's Disease (Ages 50-89)Ovarian Cancer

(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Emphysema/COPD

This study will evaluate the effects of an investigational drug on people with emphysema.

The research site is in Richmond, Va.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/copd.aspx.

-----

Alzheimer's Disease (Ages 50-89)

The study will evaluate the safety, effectiveness, and tolerability of an investigational drug to treat mild-to-moderate Alzheimer's disease.

The research site is in Philadelphia, Penn.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/alzheimer's_disease.aspx.

-----

Ovarian Cancer

This study will evaluate the investigational drug farletuzumab, given in combination with carboplatin and taxane, for women with relapsed platinum-sensitive epithelial ovarian cancer.

The research site is in Louisville, Ky.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/ovarian_cancer.aspx.

-----

Copyright 2011 ClinicalConnection.com. All rights reserved.

Related Stories

No stories found.
logo
www.healthday.com